On behalf of the programme chairs, we are delighted to invite you to the Gilead Haematology Medical Education Programme in lymphoid malignancies focusing on Chronic Lymphocytic Leukaemia (CLL) and Follicular Lymphoma (FL). This will consist of a series of regional meetings held around the UK.

These meetings will be held by regional experts and will include:

  • Latest research and deeper understanding of the biology and genetics of CLL and FL -Addressing topical questions in the light of the latest thinking and data on the treatments of lymphoid malignancies
  • Discussion on the role of cytogenetics and advanced diagnostic techniques in patient management
  • Interactive real-world case studies typically encountered by clinicians
  • A practical guide to the multi-disciplinary management of side-effects within the changing treatment landscape

We look forward to welcoming you to these meetings.

London
Friday 21st September 2018
10:00 – 15:00
Cardiff
Tuesday 9th October 2018
17:30 – 20:30
Ireland
Thursday 11th October 2018
18:00 – 19:30
Glasgow
Thursday 15th November 2018
12:00 – 18:30
Oxford
Monday 19th November 2018
10:00 – 17:00

Continuing Professional Development (CPD) accreditation for the UK meetings has been applied to the Royal College of Physicians (RCP) and more information will be available shortly. Please note, CPD credits obtained through RCP will be accepted by other medical colleges such as the Royal College of Pathologists and the Royal College of Nursing.

This is a medical education meeting organised and funded by Gilead Sciences Ltd., a science-based pharmaceutical company. This meeting is a medical education programme designed for healthcare professionals based in the UK and the Republic of Ireland only.

 

ONC/UK/18-02/NMAR/1080g(1)
Date of preparation: August 2018

This activity is intended for medical Haematology/Oncology specialists, Pathologists, Pharmacists, Nurses and other healthcare professionals involved in the management of CLL/FL. This is a medical education meeting organised and funded by Gilead Sciences Ltd., a science-based pharmaceutical company. This meeting is a medical education programme designed for healthcare professionals based in the UK and the Republic of Ireland only.